Gynecological Cancer Treatment and Surgery for International Patients in India

The Major Gynecological Cancers for International Patients in India

Cancers of the ovary, womb lining, cervix, vulva and vagina differ in cause, behaviour and treatment. Cervical cancer, for example, is linked to a virus and often treated without major surgery, while ovarian cancer is often found late and needs both surgery and chemotherapy. This is why a clear diagnosis comes before any choice of hospital.

Why International Patients Consider India

• Access to gynecologic oncologists experienced in both minimally invasive and open cancer surgery.
• Robotic surgery and sentinel-node mapping at selected centres.
• Complex ovarian cytoreduction with colorectal/hepatobiliary backup.
• Modern radiation, image-guided brachytherapy and medical oncology.
• Molecular pathology/genetic testing.
• Lower private/self-pay costs and coordinated international-patient services.

Other practical reasons include short waiting times for specialist review, English widely used in hospitals, surgery, radiation and chemotherapy available in one hospital, and package structures that can be compared item by item. None of this means every patient should travel. India is a sensible option when the diagnosis is established, imaging is complete, the patient is fit to fly and the home team will take over care afterwards. It is not a good option for someone who is bleeding heavily, septic, obstructed or rapidly deteriorating, who needs urgent local treatment first.

How Does India Compare with Other Medical Travel Destinations?

Patients often compare India with Singapore, Turkey, Thailand, South Korea or the Gulf. The honest comparison is about the whole pathway, not the price list:

What Causes Gynecological Cancer, and Who Is at Higher Risk?

Causes differ by cancer, and for many patients none is found. The factors below raise risk, although many people with risk factors never develop cancer and some with the disease have none:

Symptoms That Need Evaluation

• Postmenopausal or abnormal uterine bleeding.
• Persistent abdominal bloating, early satiety, pelvic pressure or increasing abdominal size.
• Abnormal vaginal discharge or bleeding after intercourse.
• Persistent vulvar lesion, ulcer, itching or lump.
• Pelvic pain, urinary/bowel symptoms or unexplained weight loss.

What each symptom may mean

These symptoms are common to many harmless conditions. They deserve examination and tests rather than repeated reassurance. Postmenopausal bleeding in particular should always be investigated promptly.

The Diagnostic Pathway at a Glance

Each step can change the plan, and skipping one can mean an operation that does not match the real situation. A centre that is willing to explain this sequence for your case is likely to plan carefully.

Pathology Comes First

Treatment should be based on tissue diagnosis whenever appropriate. Expert pathology review is particularly valuable for ovarian tumor subtype, uterine sarcoma vs carcinoma, high-grade endometrial histology and unusual vulvar/vaginal lesions. Gynecologic pathology is a subspecialty. A second review of your slides by an expert can change the subtype or grade, and with it the treatment, so it is often worth doing before a major operation.

Imaging

• Transvaginal/pelvic ultrasound for uterine/adnexal evaluation.
• Pelvic MRI for cervical local staging and selected uterine/vaginal disease.
• Contrast CT chest/abdomen/pelvis for ovarian and advanced cancers.
• PET-CT for selected cervical/high-risk or recurrent disease.
• Diagnostic laparoscopy for selected ovarian cancer to assess resectability.

Tumor Markers and Molecular Tests

• CA-125 in appropriate ovarian pathways; it is not a screening test by itself.
• BRCA1/2 germline/tumor testing and HRD assessment where relevant in epithelial ovarian cancer.
• MMR/MSI testing in endometrial cancer; evaluate Lynch syndrome where indicated.
• POLE and p53-based molecular classification for endometrial risk stratification where available.
• PD-L1 and other biomarkers in selected advanced/recurrent cervical or other cancers.

Molecular results can open options such as PARP inhibitors or immunotherapy, and can show an inherited risk that matters to sisters, daughters and other relatives. If testing has not been done, ask whether it can be done on stored tissue.

Records to Send Before Travel

• Biopsy/pathology report and slides/blocks if available.
• Actual CT/MRI/PET DICOM images and reports.
• Operative notes from prior surgery.
• Chemotherapy/radiation details and dates.
• Tumor-marker trends and molecular/genetic results.
• Current blood tests, medications, medical history and fertility priorities.

Treatment Options at a Glance

The first treatment depends on the cancer type, stage, your fitness and your wishes, including fertility. The table summarises how the main pathways compare, and your own team will tailor it:

Is Treatment in India Right for You? A Short Checklist

This checklist is not a decision, but it helps you see whether you are likely to be a good candidate for treatment in India. Ask yourself:

Preparing Before Travel

• Correct anemia/nutritional problems where possible.
• Optimize diabetes, blood pressure and cardiopulmonary conditions.
• Discuss anticoagulants and supplements.
• Stop smoking.
• Arrange fertility consultation urgently if relevant.
• Plan an attendant for major ovarian/pelvic surgery.
• Use flexible travel arrangements and accommodation close to the hospital.

Preparing yourself before treatment (prehab)

Prehab is not about perfection. Even two or three weeks of better nutrition, daily walking and treatment of anaemia can help, and your team will tell you how much time you can safely spend preparing without delaying treatment.

Understanding Ovarian Cancer

Most high-grade serous cancers grouped as 'ovarian' are now understood to originate from the fallopian tube. Ovarian, tubal and primary peritoneal carcinomas are staged and treated together. Ovarian cancer is often found at an advanced stage because early symptoms such as bloating and early fullness are vague. Treatment usually combines surgery to remove as much visible cancer as possible with platinum-based chemotherapy, and the order is a key decision.

Primary Surgery vs Chemotherapy First

Neither route is a failure or a compromise. Chemotherapy first can shrink disease and make a safer, more complete operation possible, while primary surgery suits patients in whom the surgeon expects to remove all visible disease. Ask which route is advised for you, and why.

What Ovarian Cytoreduction May Include for International Patients in India for Gynecological Cancer

• Hysterectomy and bilateral salpingo-oophorectomy.
• Omentectomy.
• Pelvic/para-aortic nodal assessment when indicated.
• Bowel resection.
• Diaphragm stripping/resection.
• Splenectomy and selected upper-abdominal procedures.
• Peritoneal resections.

Goal of Surgery

For advanced epithelial ovarian cancer, the objective is no gross residual disease whenever safely achievable. The quality of cytoreduction matters more than simply performing a long operation.

HIPEC

HIPEC may be considered in selected interval-debulking settings at experienced centres. It is not required for every ovarian cancer and does not replace systemic platinum-based chemotherapy.

Maintenance Treatment

PARP inhibitors and/or bevacizumab are used selectively according to BRCA/HRD status, stage, response, prior therapy and current indications.

Diagnosis and Risk Assessment

Postmenopausal bleeding should be evaluated promptly. Endometrial biopsy or hysteroscopy usually establishes diagnosis. Histology, grade, myometrial invasion, lymphovascular invasion, cervical involvement and molecular class determine recurrence risk.

Standard Surgery

For many uterine-confined cancers, total hysterectomy + bilateral salpingo-oophorectomy is performed laparoscopically or robotically, with sentinel-node staging according to risk.

Sentinel Lymph-Node Mapping

Indocyanine-green mapping can reduce the need for full pelvic lymphadenectomy in many patients while maintaining staging quality when a validated algorithm is followed.

Molecular Classification

High-Risk Histologies for International Patients in India for Gynecological Cancer

Serous carcinoma, carcinosarcoma, clear-cell and other aggressive tumors may require more extensive staging and systemic therapy.

Fertility-Sparing Endometrial Treatment

Selected young patients with grade-1 endometrioid carcinoma confined to the endometrium may be treated temporarily with high-dose progestin or levonorgestrel-IUD-based therapy under strict surveillance. Definitive hysterectomy is generally advised after childbearing.

Your Surgery Day, Step by Step

Every hospital has its own routine, but a gynecological cancer operation commonly follows this pattern:

Your companion should know where to wait and how the surgeon will update them. A long time in theatre does not by itself mean something has gone wrong, particularly in ovarian cytoreduction.

Early Cervical Cancer

• Conization for selected microinvasive disease.
• Simple or radical hysterectomy according to tumor size and contemporary risk criteria.
• Sentinel-node/pelvic nodal assessment.
• Radical trachelectomy or less-radical fertility-preserving surgery in carefully selected patients.

Radical Hysterectomy

Radical hysterectomy removes the uterus/cervix, parametrial tissue and upper vagina with nodal assessment. When radical hysterectomy is indicated, open surgery remains preferred in many patients because minimally invasive radical hysterectomy has shown inferior oncologic outcomes.

Locally Advanced Cervical Cancer

Concurrent chemoradiation followed by brachytherapy is the curative standard for most locally advanced disease. Brachytherapy is essential and should not simply be replaced by additional external-beam radiation.

Imaging and Nodes

Pelvic MRI defines local tumor extent; PET-CT helps assess nodal/distant disease in higher-risk cases. Nodal findings can alter radiation fields and systemic strategy.

Recurrent Cervical Cancer

Treatment depends on prior radiation/surgery and recurrence site. Options can include systemic therapy, salvage surgery in selected central recurrence, re-irradiation in specialized settings or palliative treatment.

Vulvar Cancer for International Patients in India for Gynecological Cancer

Persistent vulvar lesions should be biopsied before definitive large excision. Most cancers are squamous-cell carcinoma, but pathology matters.

Vulvar Surgery

• Radical local excision rather than routine historical en-bloc vulvectomy when adequate margins are achievable.
• Sentinel lymph-node biopsy for selected unifocal early tumors with clinically negative groins.
• Inguinofemoral lymphadenectomy when sentinel criteria are not met or nodes are involved.
• Plastic/reconstructive flaps for larger defects.

Advanced Vulvar Cancer

Tumors involving urethra, anus or vagina may require chemoradiation, radical surgery or a combined strategy. Organ preservation and wound morbidity are important considerations.

Vaginal Cancer

Primary vaginal cancer is uncommon. Radiation with brachytherapy is central for many patients; surgery is selected according to site, size and previous treatment.

Pelvic Exenteration

Very selected recurrent central pelvic cancers without distant disease may be considered for pelvic exenteration. This is a major operation that can require urinary and bowel diversion and reconstruction, and should be undertaken only after detailed multidisciplinary assessment.

Sexual and Functional Rehabilitation

Vaginal stenosis, sexual pain, urinary changes, lymphedema and body-image concerns should be anticipated. Rehabilitation, dilator guidance after radiation where appropriate, pelvic-floor care and counselling can be important.

Cervical, vulvar and vaginal treatment at a glance

Who May Be Eligible for Fertility Preservation?

Egg, Embryo and Ovarian-Tissue Preservation

Before gonadotoxic chemotherapy or pelvic radiation, selected patients can be referred urgently to reproductive specialists. Cancer treatment should not be delayed inappropriately.

Surgical Menopause

Premenopausal bilateral oophorectomy causes abrupt menopause. Patients should discuss vasomotor symptoms, bone health, cardiovascular health, sexual function and whether hormone therapy is safe for their cancer type.

Pregnancy After Fertility-Sparing Treatment for International Patients in India for Gynecological Cancer

Pregnancy planning should be coordinated with oncology and reproductive specialists. Surveillance must continue because fertility-preserving treatment can carry a higher need for later definitive surgery.

Where Robotic/Laparoscopic Surgery Helps

Minimally invasive hysterectomy is preferred for many uterine-confined endometrial cancers because it generally reduces wound morbidity and speeds recovery without compromising oncologic quality when appropriately performed.

Where Open Surgery May Be Better

• Radical hysterectomy for cervical cancer when indicated.
• Extensive advanced ovarian cytoreduction.
• Very large masses where intact removal is important.
• Complex recurrent cancer or multivisceral resection.

Sentinel-Node Technology

ICG fluorescence helps identify sentinel nodes in endometrial and selected cervical/vulvar pathways. Mapping failure or suspicious nodes may require additional dissection according to the cancer-specific algorithm.

Intraoperative Frozen Section

Frozen section can assist selected real-time decisions, but it is not a substitute for final pathology and may be less reliable for some tumor types.

Technology Questions to Ask

• Why is robotic/laparoscopic surgery oncologically appropriate for my exact cancer?
• What is the surgeon's volume with this procedure?
• Will the specimen be removed intact?
• What is the conversion-to-open plan?
• Is sentinel mapping appropriate, and what happens if mapping fails?

Ovarian Cancer Systemic Therapy

Platinum-taxane chemotherapy remains foundational. Bevacizumab and PARP-inhibitor maintenance are used selectively according to risk, BRCA/HRD status, response and prior therapy.

Endometrial Cancer Adjuvant Treatment

Vaginal brachytherapy, pelvic radiation and/or chemotherapy are selected by stage, pathology and molecular risk. Advanced/recurrent disease increasingly uses immunotherapy, particularly for MMRd/MSI-high tumors and in broader combinations according to current indications.

Cervical Cancer Radiation

External-beam pelvic radiation is commonly combined with weekly radiosensitizing cisplatin followed by image-guided brachytherapy. Overall treatment time matters; unnecessary delays should be avoided.

Immunotherapy and Newer Drugs for International Patients in India for Gynecological Cancer

Immune-checkpoint inhibitors and antibody-drug conjugates have important roles in selected recurrent/metastatic cervical and endometrial cancers. Exact regimens evolve and should follow current oncology guidance.

Radiation Side Effects

• Fatigue, diarrhea and urinary irritation during treatment.
• Bone-marrow suppression depending on field/systemic therapy.
• Vaginal stenosis and sexual effects.
• Premature ovarian failure in premenopausal patients.
• Late bowel/bladder toxicity in a minority of patients.
• Lymphedema when pelvic/groin nodes are treated.

Systemic and radiation treatments at a glance

Common side effects, and what helps

Surgical Risks

• Bleeding/transfusion and infection.
• Bladder, ureter or bowel injury.
• Urinary retention or bladder dysfunction after radical pelvic surgery.
• Lymphocele and leg/genital lymphedema.
• Bowel leak/fistula after cytoreductive bowel surgery.
• DVT/pulmonary embolism.
• Wound complications, particularly after vulvar/groin surgery.
• Early menopause, infertility and sexual-function changes.

No honest surgeon can quote one risk figure for all patients, because risk depends on the cancer, the extent of surgery, your fitness and earlier treatment. Ask the team for its own figures for operations like yours.

Lymphedema

Sentinel-node approaches can reduce lymphatic morbidity in eligible patients. After full pelvic or groin dissection, patients should receive education on skin care, exercise, early swelling recognition and specialist therapy.

Obesity, Diabetes and Older Age

These do not automatically exclude surgery but can increase wound, thrombotic and medical risks. Optimization and minimally invasive approaches may be particularly valuable when oncologically appropriate.

Previous Surgery or Radiation

Prior treatment can increase adhesions, fibrosis, fistula risk and reconstructive complexity. Recurrent cancer surgery should be planned at centres accustomed to salvage operations.

What Could Go Wrong, and How Likely Is It?

Warning Symptoms After Discharge

• Fever, increasing wound redness/drainage.
• Heavy vaginal bleeding.
• Increasing abdominal pain/distension or persistent vomiting.
• Leg swelling, chest pain or breathlessness.
• Difficulty passing urine or reduced urine output.
• Severe diarrhea/dehydration during radiation.
• Groin/vulvar wound breakdown or increasing swelling.

Some signs need quick action. Share the table below with your companion, and keep the hospital's emergency number on your phone.

What You Can Do to Reduce Your Risk

Recovery Timeline

The table above gives hospital and planning times by operation. The table below shows what you and your companion may experience week by week after a major operation, and a minimally invasive hysterectomy is faster.

Fit to Fly for International Patients in India for Gynecological Cancer

Clearance depends on wound healing, mobility, anemia, bowel/bladder function, catheter/drain status and DVT risk. Major pelvic/abdominal cancer surgery often warrants extended thromboprophylaxis.

Accommodation and Attendant

Choose lift access, a safe bathroom, easy transport to the hospital and adequate space for an attendant. After vulvar surgery, wound care and comfortable sitting may require special planning.

Airport Planning

• Request wheelchair assistance in advance.
• Carry medicines, prescriptions and medical summary in hand luggage.
• Use an aisle seat and walk when safe on long flights.
• Continue prescribed anticoagulation exactly as directed.
• Carry catheter/stoma supplies if applicable.
• Keep return travel flexible until surgeon clearance.

Practical Questions Patients Ask After the Operation

When can I eat normally? Usually from the first days after surgery, starting with small meals. Appetite may stay low for a few weeks. When can I walk and exercise? Walking begins in hospital within a day or two. Gentle daily walking increases over weeks, and heavy lifting waits until your surgeon allows it. Will I have a catheter or drain at home? Often the catheter is removed in hospital. If a drain or catheter is needed, you will be taught how to care for it. When can I drive or work? Often after several weeks to a couple of months, depending on the operation and the type of work. When can I have sex again? Usually once healing is complete and your surgeon agrees, often six weeks or more after hysterectomy. Ask in advance and about support after radiation. Will I go through menopause? If both ovaries are removed before menopause, yes, abruptly. Your team will discuss symptom control, bone and heart health, and whether hormone therapy is safe for you. When will I know the final pathology? Often within about a week. This report decides whether you need further treatment. Will I need chemotherapy or radiation afterwards? Depending on the cancer and pathology, often yes. Your team will agree a plan, ideally before you leave India. Can I have follow-up care at home? Yes. A home gynecologic or medical oncologist can manage scans, blood tests and treatment, and your records from India guide the plan. Will the cancer come back? It can, depending on the cancer and stage. That is why follow-up continues for years.

Travel Practicalities After Gynecological Cancer Surgery

Living After Treatment at a Glance

Emotional Wellbeing and Realistic Expectations

A diagnosis of gynecological cancer is frightening, and for many women it brings grief about fertility, changes to body image and worries about intimacy. It is normal to feel anxious, tired, angry or low at times. Some women search for a reason why this happened, but these cancers are not a punishment and nothing you did caused the cancer to appear, so what matters now is the plan ahead, not blame. Ask your team what to expect, and say so if low mood, anxiety or poor sleep continues, because these respond to treatment. Counselling, support groups and sexual-health services can help, and your partner or companion may need support too.

Special Situations

Surveillance

Follow-up schedules vary by cancer. Surveillance can include clinical examination, symptom review, imaging, tumor markers in selected ovarian pathways, cervical/vaginal examination and management of treatment effects. Routine tests should be cancer-specific rather than performed indiscriminately.

Choosing a Gynecologic Oncologist for International Patients in India for Gynecological Cancer

• How many operations of my exact type does the surgeon perform?
• Do they perform both minimally invasive and complex open surgery?
• For ovarian cancer, do they routinely perform upper-abdominal and bowel procedures or work with dedicated surgical teams?
• What is their complete-cytoreduction rate in advanced ovarian cancer?
• What are their complication, conversion and reoperation rates?
• Do they participate in a multidisciplinary tumor board?

Four more questions to ask

• Will the surgeon who reviews my records be the one who operates, and who will assist?
• Will my case be discussed with radiation and medical oncologists before treatment is decided?
• Can I speak with a previous international patient, or see the ward and ICU?
• Who will manage my chemotherapy or radiation if I continue treatment at home?

Hospital Capabilities

• Gynecologic oncology and advanced laparoscopy/robotics.
• Complex surgical oncology/colorectal/hepatobiliary backup.
• Radiation oncology with brachytherapy.
• Medical oncology and infusion services.
• Expert gynecologic pathology and molecular testing.
• ICU, blood bank and interventional radiology.
• Genetics and fertility services.
• Lymphedema, stoma, nutrition and rehabilitation support.

What a Good International Patient Service Should Provide

Red Flags

• Robotic surgery recommended solely because it is available.
• Radical hysterectomy proposed for cervical cancer without discussing the open-vs-minimally-invasive evidence.
• Locally advanced cervical cancer treated without a brachytherapy plan.
• Advanced ovarian surgery promised without assessment of resectability or surgical complexity.
• No discussion of fertility or menopause in a young patient.
• A fixed package before pathology/stage review.

Realistic Outcomes

Outcome depends on stage, histology, molecular biology, completeness of surgery, response to systemic/radiation treatment and overall health. No responsible centre should guarantee cure.

What to Expect: A Realistic Picture

No guide can tell you your own outlook, which only your doctors can estimate from your cancer type, stage and biology. In general terms:

Use these as orientation only. Ask your own team what your cancer-specific and stage-specific figures and goals of treatment are, and be wary of any centre that quotes an unusually high success rate without stating the cancer type, stage and molecular results.

Gynecological Cancer Surgery Cost in India

These are planning ranges only. The final cost depends on what is found and done at surgery, so a firm quotation can only follow review of your own records.

Why Prices Differ

• Robotic vs open approach.
• Sentinel-node vs full lymphadenectomy.
• Bowel/upper-abdominal resection.
• ICU and transfusion needs.
• HIPEC where selected.
• Reconstruction or urinary/bowel diversion.
• Hospital stay and complications.
• Molecular pathology/genetic tests.
• Radiation/brachytherapy and systemic drugs.

India vs Other Countries

*Broad planning comparisons, not equivalent quotations. Savings are calculated against the India midpoint, and rounded. Radiation, brachytherapy, systemic drugs and exenterative surgery require separate individualised estimates, and costs in every country vary widely between hospitals.

Package Inclusions and Exclusions for International Patients in India for Gynecological Cancer

• Surgeon, assistant and anesthetist fees.
• Robotic/platform/disposable charges if used.
• Hospital/ICU nights and room category.
• Sentinel-node dye/pathology.
• Blood products policy.
• Final histopathology and molecular tests.
• Stoma/reconstruction costs if relevant.
• Complication and extended-stay exclusions.
• Radiation, brachytherapy and systemic treatment quoted separately unless explicitly included.

Budgeting for the Whole Pathway, Not Just the Operation

The hospital quote is only part of the budget. A realistic plan also includes:

• Return flights for you and a companion, with flexible dates.
• Accommodation and meals for one to three weeks or longer in India, and weeks for chemoradiation.
• Staging scans, molecular and genetic testing, and second-opinion pathology if needed.
• Chemotherapy, radiation and brachytherapy, which are usually quoted separately.
• Menopause, nutrition, lymphoedema and rehabilitation support.
• Medical visa fees and travel insurance that covers complications.
• Follow-up scans and consultations at home.
• A contingency for a longer stay, extra ICU days, a repeat procedure or a change of plan after staging.

Quotation Comparison Table

Use this table to compare written quotations from two hospitals on the same terms:

What Should the Quotation Say About Complications?

• Who pays if a complication such as bleeding, infection or a bowel or bladder injury occurs during the same admission?
• What is charged if the stay is longer than planned, ICU care is extended or a second procedure is needed?
• Whether a return to the operating room or a drainage procedure is covered, and for how long after surgery.
• What follow-up consultations, scans and pathology review are included before you leave India.
• Whether remote follow-up with the team after you return home is free or charged.

Remote Case Review Before Travel

Send your records first and ask for a written opinion before booking any flight. A good review confirms the cancer type and stage as far as can be judged, says whether surgery is the right first treatment, describes the proposed procedure and its effect on fertility, and indicates whether radiation, brachytherapy or chemotherapy will be needed. If the team advises treatment at home, or a different plan, that is useful information, not a lost sale.

Typical Surgical Journey

Cervical Chemoradiation Journey

Patients travelling specifically for chemoradiation should plan for simulation, external-beam treatment over several weeks, concurrent chemotherapy, brachytherapy sessions and recovery. Accommodation and visa duration should reflect the full course, not just the first consultation.

Medical Visa

Confirm current Indian medical/e-Medical visa eligibility and attendant rules for your nationality. Hospitals generally provide treatment/invitation letters after medical review. Rules can change.

Most patients apply for an e-Medical Visa, and a companion can apply for an e-Medical Attendant Visa. Check the current fees, validity and eligible nationalities on the official Indian e-Visa website before applying. If you may need chemoradiation or a longer stay, ask about visa validity and extension.

What to Carry Home

• Final pathology and stage.
• Operative report.
• Molecular/genetic results.
• Radiation plan and dose summary if treated.
• Chemotherapy/immunotherapy records.
• Medication and anticoagulation list.
• Catheter/stoma/wound instructions.
• Written adjuvant-treatment and surveillance plan.
• Emergency contact details.

Your information pack: why each item matters

Arranging Your Follow-Up at Home Before You Leave

Identify a gynecologic or medical oncologist, a radiation oncologist if needed, and where relevant a lymphoedema therapist, sexual-health service and counsellor at home who are willing to see you, review your records and continue treatment and surveillance. Send them the records before you arrive and agree how they will contact your surgeon in India. This one step does more for safe recovery than almost any other.

Language, Consent and Communication for International Patients in India for Gynecological Cancer

• Ask for the consent form and discharge instructions in a language you understand.
• Ask for an interpreter if your English is limited; do not rely on guesses for risks or medicines.
• Make sure the consent explains the planned operation and what may be removed, the effect on fertility and menopause, the chance of bleeding or injury to nearby organs, and what will be done if more disease is found during surgery.
• Agree who will receive updates, and how, if you cannot answer on the day.
• Save the hospital, surgeon, oncologist and coordinator contact numbers before you travel, and keep your own copies of everything you sign.

Questions to Ask Before Committing

• What is my exact histology, stage and molecular subtype?
• Is surgery the correct first treatment?
• Is minimally invasive surgery oncologically appropriate?
• Can sentinel mapping replace full node dissection?
• Can fertility safely be preserved?
• For ovarian cancer, is no-gross-residual cytoreduction realistic?
• Do I need BRCA/MMR/POLE/p53 testing?
• Will I need brachytherapy?
• What are the likely urinary, bowel, sexual and menopausal effects?
• How long should I remain in India?
• Who will give chemotherapy or radiation if I continue treatment at home?
• What will it cost if the plan changes or complications occur?

Ten FAQs

1. Is surgery always first for ovarian cancer?

No. Primary surgery is preferred when complete cytoreduction is realistically achievable; otherwise biopsy and neoadjuvant chemotherapy followed by interval surgery may be safer.

2. Is robotic surgery appropriate for endometrial cancer?

Yes. It is preferred for many uterine-confined endometrial cancers when performed by an experienced team.

3. Is robotic radical hysterectomy recommended for cervical cancer?

Generally not when radical hysterectomy is required; open surgery remains preferred in many patients because minimally invasive radical hysterectomy has shown inferior oncologic outcomes.

4. Can cervical cancer be cured without surgery?

Yes. Chemoradiation plus brachytherapy is curative standard treatment for most locally advanced cervical cancers.

5. What is sentinel-node mapping?

A tracer identifies the first draining lymph nodes, allowing focused removal and potentially reducing lymphedema in eligible patients.

6. Can fertility be preserved?

Sometimes, in strictly selected early cervical, endometrial or ovarian tumors with close surveillance.

7. Do all ovarian cancer patients need HIPEC?

No. HIPEC is considered only in selected settings.

8. Why are BRCA and MMR tests important?

They can guide targeted/immunotherapy and may identify hereditary cancer risk relevant to relatives.

9. How long should I stay in India?

Routine minimally invasive surgery often needs about 7-14 days; major ovarian cytoreduction commonly needs 2-3 weeks or longer. Radiation pathways can require several weeks.

10. What should I send for an opinion?

Pathology, actual imaging, prior operative notes, chemotherapy/radiation records, tumor markers, molecular/genetic results and current medical information.

11. Will I go into menopause after treatment?

If both ovaries are removed, or after pelvic radiation, before natural menopause, yes. Your team can advise on symptom control, bone and heart health and whether hormone therapy is safe for your cancer.

12. Can I still have sex after treatment?

Often yes, once healing is complete. Vaginal dryness or narrowing after radiation or surgery is common, and dilators, lubricants and counselling help.

13. Should my relatives be tested?

If a hereditary syndrome such as BRCA or Lynch syndrome is found, relatives may be offered genetic counselling and testing. Ask your team.

14. Is HPV vaccination relevant after a diagnosis of cervical cancer?

Vaccination protects against new HPV infections, mainly in younger people, and is advised for daughters and other relatives. Ask your doctor whether it adds anything in your case.

15. What if my cancer is found to be more advanced during surgery?

The surgeon will complete what is safe and appropriate, take biopsies where needed and then plan chemotherapy or radiation. This is why consent covers the full range of possibilities.

16. Do I need a companion?

Yes, for a major operation or a long course of chemoradiation. A companion helps with decisions, practical tasks and care, and can apply for an attendant visa.

Planning Gynecological Cancer Treatment – Checklist for International Patients in India

Sources

1. 1. Cleveland Clinic - Gynecologic Cancer: Get the Facts: https://my.clevelandclinic.org/health/transcripts/13000_gynecologic-cancer-get-the-facts
2. 2. Mayo Clinic - Ovarian cancer care at Mayo Clinic: https://www.mayoclinic.org/diseases-conditions/ovarian-cancer/care-at-mayo-clinic/mac-20375946
3. 3. Government of India - Indian Visa Online (e-Medical Visa and e-Medical Attendant Visa): https://indianvisaonline.gov.in/evisa/